Read more about the article Nasopharyngeal Carcinoma – Toripalimab, A New Breakthrough Drug
Nasopharyngeal Carcinoma – Toripalimab, A New Breakthrough Drug

Nasopharyngeal Carcinoma – Toripalimab, A New Breakthrough Drug

Overview Nasopharyngeal carcinoma is a malignant tumor that affects the head and neck. Typically, this cancer starts in the upper part of the throat and spreads from there. Unfortunately, metastatic…

Continue ReadingNasopharyngeal Carcinoma – Toripalimab, A New Breakthrough Drug
Read more about the article Triple Negative Breast Cancer – Leronlimab Plus Chemo Appears to Prolong Survival
Triple Negative Breast Cancer - Leronlimab Plus Chemo Appears to Prolong Survival

Triple Negative Breast Cancer – Leronlimab Plus Chemo Appears to Prolong Survival

Straight to the Point in Triple Negative Breast Cancer Leronlimab (PRO 140) has demonstrated promising preliminary results in a phase 1b/2 clinical trial (NCT03838367) for patients with metastatic triple negative…

Continue ReadingTriple Negative Breast Cancer – Leronlimab Plus Chemo Appears to Prolong Survival
Read more about the article The standard protocol – do the same and get the same. Upsetting!
הפרוטוקול הסטנדרטי - עושים אותו דבר ומקבלים אותו דבר. מרגיז!

The standard protocol – do the same and get the same. Upsetting!

The treatment that is given "according to the book" to everyone, is called in professional language "the standard protocol". LB, our client, 62, was diagnosed with stage 4 cancer three…

Continue ReadingThe standard protocol – do the same and get the same. Upsetting!
Read more about the article Prostate Cancer Breakthrough Drug Combination for Metastatic Patients
סרטן ערמונית - שילוב תרופות פורץ דרך לחולים גרורתיים

Prostate Cancer Breakthrough Drug Combination for Metastatic Patients

Background Despite the advances and strides that modern medicine has made, prostate cancer treatment options remain to be fairly reserved. However, the day is finally here that more methods of…

Continue ReadingProstate Cancer Breakthrough Drug Combination for Metastatic Patients